EP2076530A4 - Avian derived erythropoietin - Google Patents

Avian derived erythropoietin

Info

Publication number
EP2076530A4
EP2076530A4 EP07839423A EP07839423A EP2076530A4 EP 2076530 A4 EP2076530 A4 EP 2076530A4 EP 07839423 A EP07839423 A EP 07839423A EP 07839423 A EP07839423 A EP 07839423A EP 2076530 A4 EP2076530 A4 EP 2076530A4
Authority
EP
European Patent Office
Prior art keywords
derived erythropoietin
avian derived
avian
erythropoietin
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07839423A
Other languages
German (de)
French (fr)
Other versions
EP2076530A1 (en
Inventor
Robert D Ivarie
Guodong Liu
Jeffrey C Rapp
Julie A Morris
Alex J Harvey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Georgia
University of Georgia Research Foundation Inc UGARF
Synageva Biopharma Corp
Original Assignee
University of Georgia
University of Georgia Research Foundation Inc UGARF
Synageva Biopharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Georgia, University of Georgia Research Foundation Inc UGARF, Synageva Biopharma Corp filed Critical University of Georgia
Publication of EP2076530A1 publication Critical patent/EP2076530A1/en
Publication of EP2076530A4 publication Critical patent/EP2076530A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP07839423A 2006-11-09 2007-10-10 Avian derived erythropoietin Withdrawn EP2076530A4 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US85789606P 2006-11-09 2006-11-09
US87760106P 2006-12-28 2006-12-28
US91850407P 2007-03-16 2007-03-16
PCT/US2007/021643 WO2008057161A1 (en) 2006-11-09 2007-10-10 Avian derived erythropoietin

Publications (2)

Publication Number Publication Date
EP2076530A1 EP2076530A1 (en) 2009-07-08
EP2076530A4 true EP2076530A4 (en) 2010-04-07

Family

ID=39364811

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07839423A Withdrawn EP2076530A4 (en) 2006-11-09 2007-10-10 Avian derived erythropoietin

Country Status (6)

Country Link
EP (1) EP2076530A4 (en)
JP (1) JP2010509327A (en)
KR (1) KR20090090328A (en)
AU (1) AU2007318209A1 (en)
CA (1) CA2668487A1 (en)
WO (1) WO2008057161A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2230900A4 (en) * 2008-01-07 2013-01-09 Synageva Biopharma Corp Glycosylation in avians
MX2012003558A (en) * 2009-09-23 2012-07-03 Biogenerix Ag Process for the purification of recombinant human erythropoietin (epo), epo thus purified and pharmaceutical compositions comprising same.
US20140066379A1 (en) * 2012-08-30 2014-03-06 Body Organ Biomedical Corp. Recombinant vector, transgenic fish egg using the same and biomaterial using the same
WO2017169978A1 (en) * 2016-03-31 2017-10-05 株式会社カネカ Method for producing purified feline erythropoietin
JP7027347B2 (en) * 2016-08-23 2022-03-01 アレクシオン ファーマシューティカルズ インコーポレイテッド How to purify heterologous proteins from egg white

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004067713A2 (en) * 2003-01-24 2004-08-12 Avigenics Inc. Exogenous proteins expressed in avians and their eggs
WO2006112147A1 (en) * 2005-03-30 2006-10-26 Kaneka Corporation Transgenic bird producing erythropoietin and method of constructing the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69842019D1 (en) * 1997-10-16 2011-01-05 Synageva Biopharma Corp TRANSGENIC BIRDS AND PROTEIN PRODUCTION
US7129390B2 (en) * 1997-10-16 2006-10-31 Avigenics, Inc Poultry Derived Glycosylated Interferon Alpha 2b
ES2273497T3 (en) * 1998-06-15 2007-05-01 Gtc Biotherapeutics, Inc. FUSION PROTEIN OF THE SERIAL HUMAN ALBUMIN OF ERITROPOYETINA ANALOGA.
WO2003025146A2 (en) * 2001-09-18 2003-03-27 Avigenics, Inc. Production of a transgenic avian by cytoplasmic injection

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004067713A2 (en) * 2003-01-24 2004-08-12 Avigenics Inc. Exogenous proteins expressed in avians and their eggs
WO2006112147A1 (en) * 2005-03-30 2006-10-26 Kaneka Corporation Transgenic bird producing erythropoietin and method of constructing the same
US20090064351A1 (en) * 2005-03-30 2009-03-05 Kaneka Corporation Transgenic bird producing erythropoietin and method of constructing the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2008057161A1 *

Also Published As

Publication number Publication date
CA2668487A1 (en) 2008-05-15
JP2010509327A (en) 2010-03-25
EP2076530A1 (en) 2009-07-08
AU2007318209A1 (en) 2008-05-15
WO2008057161A1 (en) 2008-05-15
KR20090090328A (en) 2009-08-25

Similar Documents

Publication Publication Date Title
CR10841A (en) IMIDAZOTRIAZINAS IMIDAZOPIRIMIDINAS INHIBIDORES DE CINASA
GB0600488D0 (en) Immunoglobulins
DK2187759T3 (en) Erythritol-based hard coatings
IL182741A0 (en) Improved coatings
ZA200709091B (en) Erythropoietin variants
DE502006006067D1 (en) NG
IL197475A0 (en) Long-term feed-elderly
IL232923A0 (en) Modified erythropoietin
EP1997505A4 (en) Erythropoietin solution preparation
BRPI0908866A2 (en) mastics
AP2008004724A0 (en) Substituted1-yl)-azolin-2-aryl-1-hetaryl-ethane
EP2076530A4 (en) Avian derived erythropoietin
GB0606679D0 (en) Aerofoil
GB2439330B (en) Aerofoil
SE0601926L (en) Cookware
GB2453013B (en) Improved incapacitant spray
GB0713585D0 (en) Equivalent
GB0715126D0 (en) Erythropoietin
GB0809208D0 (en) Erythropoietin
GB2436448B (en) Assembly
GB0612151D0 (en) Bird scarer
IL175810A0 (en) Bird scarer
FI20060530A0 (en) SKIRT
FI20065703A0 (en) painting Line
AU315044S (en) Ornamanetal object

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090331

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: MORRIS, JULIE A.

Inventor name: RAPP, JEFFREY C.

Inventor name: LIU, GUODONG

Inventor name: HARVEY, ALEX J.

Inventor name: IVARIE, ROBERT D.

A4 Supplementary search report drawn up and despatched

Effective date: 20100310

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090911

R18D Application deemed to be withdrawn (corrected)

Effective date: 20100609